Eric Brodersen
Analyst · Canaccord Genuity. Please go ahead
Thank you, Chris. Third quarter revenue was $40.8 million, a new company record. Revenue grew 18.5% year-over-year, and 6.7% quarter-over-quarter, compared with $34.4 million in third quarter 2018 and $38.2 million in second quarter 2019, respectively. Third quarter endpoint IC revenue was $26.4 million, growing 11.2% both year-over-year and quarter-over-quarter, compared with $23.7 million in both third quarter 2018 and second quarter 2019. Third quarter systems revenue was $14.4 million, growing 34.6% year-over-year compared with $10.7 million in third quarter 2018, led again by the large North American gateway project, as well as by strong reader sales, partially offset by a decline in reader IC revenue. On a quarter-over-quarter basis, systems revenue declined 0.6% compared with $14.5 million in second quarter 2019, primarily due to modest declines in reader and reader IC revenue, partially offset by growth in gateway revenue. Third quarter gross margin was 50.2%, compared with 50.0% both a year ago and last quarter. The 20 basis-point year-over-year improvement was driven primarily by leverage on the increased revenue partially offset by product mix. Total third quarter operating expense was $18.3 million, compared with $18.1 million in third quarter 2018, and $18.3 million in second quarter 2019. Research and development expense was $8.1 million. Sales and marketing expense was $6.1 million. General and administrative expense was $4.1 million. Adjusted EBITDA for the third quarter was $2.1 million compared with a loss of $900,000 in third quarter 2018 and a profit of $800,000 in second quarter 2019. The $3 million year-over-year improvement in adjusted EBITDA marks another quarter of solid execution. GAAP net loss for the third quarter was $4.1 million. Non-GAAP net income for the third quarter was $1.9 million or $0.09 per share, using a weighted-average diluted share count of 22.9 million shares. Turning to the balance sheet. We ended the second quarter with cash, cash equivalents and short-term investments of $63.1 million, compared with $59.8 million in the prior quarter and $54.7 million in third quarter 2018. Inventory totaled $36.3 million, down $1.6 million from the prior quarter and down $12.9 million from third quarter 2018. Since early 2018, we have made significant progress reducing internal inventory. As we ramp Impinj M700 production and pursue emerging market opportunities, we expect inventory to increase in the fourth quarter. Before I turn to fourth quarter guidance, I want to highlight a few items. First, we continue investing in our business and expect research and development, capital and legal expenses to increase. We continue driving a robust research and development pipeline, including further endpoint IC innovations and a systems focus expanded to include item-based loss prevention. We remain committed to investing in that research and those product developments as growth drivers for our future, increasing our R&D spend on both a percentage basis and in absolute dollars. As always, we make every investment decision through the lens of balancing our desire to achieve adjusted EBITDA and free cash flow breakeven, with an equally important desire to invest in our vision, our team and in game changing innovations like the M700. Second, I would like to remind you of the seasonality trends we typically see in our business. In the fourth quarter, we typically see lower endpoint IC volumes partially offset by stronger systems sales. In the first quarter, annual pricing negotiations typically impact endpoint IC revenue and gross margin while systems sales tend to be seasonally lower. Also, in the first quarter, operating expenses tend to increase over the prior quarter due to payroll tax resets and increased healthcare costs. Although these trends are typical, any number of factors can mask that seasonality including project-based systems revenue where size, timing and mix can impact our quarterly results. Turning to our outlook. We expect fourth quarter revenue to be between $37 million and $39 million, a 10% year-over-year improvement at the midpoint of the range. We expect adjusted EBITDA to be between a loss of $500,000 and a positive $1.0 million. On the bottom line, we expect non-GAAP net income between a loss of $700,000 and a positive $900,000, reflecting non-GAAP per share earnings of between minus $0.03 and plus $0.04 on a weighted-average diluted share count of 22.1 million shares to 23.1 million shares. In closing, I want to thank our team, our customers, our suppliers and our investors for your ongoing support. I will now turn the call to the operator to open the question-and-answer session.